$NURO
NeuroMetrix, Inc.

2018 Q1 Form 10-Q Financial Statement

#000162828018004797 Filed on April 20, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $4.943M $4.306M
YoY Change 14.79% 89.26%
Cost Of Revenue $2.955M $2.698M
YoY Change 9.55% 81.96%
Gross Profit $1.988M $1.671M
YoY Change 18.98% 110.75%
Gross Profit Margin 40.21% 38.8%
Selling, General & Admin $4.309M $4.019M
YoY Change 7.2% 4.89%
% of Gross Profit 216.77% 240.59%
Research & Development $1.280M $903.3K
YoY Change 41.66% -21.91%
% of Gross Profit 64.37% 54.07%
Depreciation & Amortization $55.44K $61.58K
YoY Change -9.96% -0.1%
% of Gross Profit 2.79% 3.69%
Operating Expenses $5.588M $4.923M
YoY Change 13.52% -1.33%
Operating Profit -$3.601M -$3.314M
YoY Change 8.64% -21.02%
Interest Expense $80.00K
YoY Change -20.0%
% of Operating Profit
Other Income/Expense, Net $10.00K
YoY Change
Pretax Income $1.170M -$3.230M
YoY Change -136.22% -21.22%
Income Tax
% Of Pretax Income
Net Earnings $1.166M -$3.232M
YoY Change -136.08% -21.07%
Net Earnings / Revenue 23.59% -75.07%
Basic Earnings Per Share $0.18 -$7.27
Diluted Earnings Per Share $0.08 -$7.27
COMMON SHARES
Basic Shares Outstanding 6.346M shares 1.001M shares
Diluted Shares Outstanding 13.73M shares 1.001M shares

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.100M $6.900M
YoY Change -11.59% -21.05%
Cash & Equivalents $6.100M $6.897M
Short-Term Investments
Other Short-Term Assets $950.0K $1.420M
YoY Change -33.1% 97.22%
Inventory $1.859M $1.197M
Prepaid Expenses
Receivables $1.589M $950.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.50M $10.46M
YoY Change 0.33% -8.69%
LONG-TERM ASSETS
Property, Plant & Equipment $431.7K $471.1K
YoY Change -8.38% -27.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $40.00K $150.0K
YoY Change -73.33% -21.05%
Total Long-Term Assets $474.8K $625.5K
YoY Change -24.09% -26.41%
TOTAL ASSETS
Total Short-Term Assets $10.50M $10.46M
Total Long-Term Assets $474.8K $625.5K
Total Assets $10.97M $11.09M
YoY Change -1.05% -9.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $384.1K $404.1K
YoY Change -4.95% -70.72%
Accrued Expenses $2.361M $1.395M
YoY Change 69.27% -25.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.150M $3.065M
YoY Change 35.39% -6.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $170.0K
YoY Change -10.53%
Total Long-Term Liabilities $0.00 $170.0K
YoY Change -100.0% -10.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.150M $3.065M
Total Long-Term Liabilities $0.00 $170.0K
Total Liabilities $4.150M $3.237M
YoY Change 28.22% -6.44%
SHAREHOLDERS EQUITY
Retained Earnings -$189.9M -$181.7M
YoY Change 4.51%
Common Stock $714.00 $874.00
YoY Change -18.31% 99.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.823M $7.852M
YoY Change
Total Liabilities & Shareholders Equity $10.97M $11.09M
YoY Change -1.05% -9.92%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $1.166M -$3.232M
YoY Change -136.08% -21.07%
Depreciation, Depletion And Amortization $55.44K $61.58K
YoY Change -9.96% -0.1%
Cash From Operating Activities $2.080M -$3.350M
YoY Change -162.09% -7.46%
INVESTING ACTIVITIES
Capital Expenditures $25.83K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$25.83K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 6.300M
YoY Change -100.0% -7975.0%
NET CHANGE
Cash From Operating Activities $2.080M -3.350M
Cash From Investing Activities -$25.83K 0.000
Cash From Financing Activities 0.000 6.300M
Net Change In Cash $2.054M 2.950M
YoY Change -30.37% -179.09%
FREE CASH FLOW
Cash From Operating Activities $2.080M -$3.350M
Capital Expenditures $25.83K $0.00
Free Cash Flow $2.054M -$3.350M
YoY Change -161.32% -8.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001289850
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7356731 shares
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2361257 USD
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6903507 shares
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
796192 shares
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1049329 USD
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1588720 USD
CY2017Q4 us-gaap Accrued Advertising Current And Noncurrent
AccruedAdvertisingCurrentAndNoncurrent
160800 USD
CY2018Q1 us-gaap Accrued Advertising Current And Noncurrent
AccruedAdvertisingCurrentAndNoncurrent
99400 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2362124 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
603000 USD
CY2018Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
341000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
196355142 USD
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
196695736 USD
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000 USD
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
NeuroMetrix, Inc.
CY2018Q1 dei Trading Symbol
TradingSymbol
NURO
CY2017Q4 nuro Accrued Compensation
AccruedCompensation
786184 USD
CY2018Q1 nuro Accrued Compensation
AccruedCompensation
1029747 USD
CY2017Q4 nuro Accrued Sales Return Provisions
AccruedSalesReturnProvisions
666375 USD
CY2018Q1 nuro Accrued Sales Return Provisions
AccruedSalesReturnProvisions
1405117 USD
CY2017Q1 nuro Increase Decreasein Accrued Product Returns
IncreaseDecreaseinAccruedProductReturns
-161856 USD
CY2018Q1 nuro Increase Decreasein Accrued Product Returns
IncreaseDecreaseinAccruedProductReturns
-553439 USD
CY2018Q1 nuro Restricted Cash Collateral Letters Of Credit
RestrictedCashCollateralLettersOfCredit
226731 USD
CY2017Q4 nuro Technology Fees
TechnologyFees
450000 USD
CY2018Q1 nuro Technology Fees
TechnologyFees
450000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
733305 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
384065 USD
CY2017Q4 us-gaap Assets
Assets
9599224 USD
CY2018Q1 us-gaap Assets
Assets
10972963 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
9103374 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
10498149 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3949135 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6897161 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4043681 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6097792 USD
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6100000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2948026 USD
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2054111 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2706066 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7141940 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2706066 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7141940 shares
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-77601 USD
CY2018Q1 us-gaap Gross Profit
GrossProfit
1987730 USD
CY2018Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1421782 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1804143 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
1608520 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-329980 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-369665 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
271 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
714 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
2697602 USD
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
2955260 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
820031 USD
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2017Q1 us-gaap Depreciation
Depreciation
61579 USD
CY2018Q1 us-gaap Depreciation
Depreciation
55444 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.27
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.27
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.27
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
314025 USD
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
211240 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-814108 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
121822 USD
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-868 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
116968 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-55379 USD
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-283909 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-236859 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-343177 USD
CY2017Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0 shares
CY2018Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
7380895 shares
CY2017Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
81858 USD
CY2018Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
11265 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1637268 USD
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1289722 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
2142561 USD
CY2018Q1 us-gaap Inventory Net
InventoryNet
1858652 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
505293 USD
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
568930 USD
CY2017Q4 us-gaap Liabilities
Liabilities
4581835 USD
CY2018Q1 us-gaap Liabilities
Liabilities
4150439 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9599224 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10972963 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4581835 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4150439 USD
CY2018Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2019-01-15
CY2018Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2500000 USD
CY2018Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
2300000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6302000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-25833 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3353974 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2079944 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-3232400 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
1166252 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7274082 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1166252 USD
CY2017Q1 us-gaap Noninterest Income
NoninterestIncome
0 USD
CY2018Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
4755705 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4922778 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
5588448 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3314258 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3600718 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
234779 USD
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
263958 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2017Q1 us-gaap Other Income
OtherIncome
81858 USD
CY2018Q1 us-gaap Other Income
OtherIncome
4766970 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25833 USD
CY2017Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4041682 USD
CY2018Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1867803 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
952985 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
55008 USD
CY2018Q1 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
43158 USD
CY2018Q1 us-gaap Proceeds From Collaborators
ProceedsFromCollaborators
5000000 USD
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6302000 USD
CY2018Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
127361 USD
CY2018Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
177152 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
440842 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
431656 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
903284 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1279564 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-191338054 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189873944 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189900000 USD
CY2017Q1 us-gaap Revenues
Revenues
4306122 USD
CY2018Q1 us-gaap Revenues
Revenues
4942990 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2597712 USD
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2504741 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
66496 USD
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
341026 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
5017389 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
6822524 USD
CY2017Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.125
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1000988 shares
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13726614 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1000988 shares
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6345719 shares
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001628280-18-004797-index-headers.html Edgar Link pending
0001628280-18-004797-index.html Edgar Link pending
0001628280-18-004797.txt Edgar Link pending
0001628280-18-004797-xbrl.zip Edgar Link pending
a10q3312018document.htm Edgar Link pending
a10q3312018ex311.htm Edgar Link pending
a10q3312018ex312.htm Edgar Link pending
a10q3312018ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nuro-20180331.xml Edgar Link completed
nuro-20180331.xsd Edgar Link pending
nuro-20180331_cal.xml Edgar Link unprocessable
nuro-20180331_def.xml Edgar Link unprocessable
nuro-20180331_lab.xml Edgar Link unprocessable
nuro-20180331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending